3D Brown Adipose Stem Cell Aggregates for Metabolic Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current therapeutic approaches for obesity and metabolic disorders, such as caloric restriction and exercise, are ineffective for many patients, and bariatric surgery carries risks and high costs.
Innovation Solution
Development of non-naturally occurring three-dimensional brown adipose-derived stem cell aggregates (BAGs) that express brown adipocyte genes without differentiation medium, which can be differentiated into brown adipose tissue and delivered via encapsulation systems for therapeutic use.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional therapeutic approaches (caloric restriction and exercise) are used to treat obesity, then weight loss may be achieved, but effectiveness is limited and relies on patient willpower
Solution Approach 1:
The patent applies self-service by using brown adipose-derived stem cells that autonomously differentiate into brown adipose tissue capable of thermogenesis. The cells automatically respond to cold stimuli and metabolic signals to increase energy expenditure without requiring continuous patient effort or willpower, transforming the therapy from behavior-dependent to biologically autonomous.
Solution Approach 2:
The patent changes the physiological parameter of energy expenditure by introducing brown adipose tissue with high thermogenic capacity. The differentiated brown adipocytes express uncoupling protein 1 (UCP1) that dissipates metabolic energy as heat, fundamentally altering the patient's metabolic rate from a low-energy state to a high-energy expenditure state, thereby achieving weight loss through physiological modification rather than behavioral control.
2Reliability
If bariatric surgery is used to treat severe obesity, then weight loss and decreased morbidity are achieved, but risks, high costs, and management requirements increase
Solution Approach 1:
The patent replaces the mechanical intervention of bariatric surgery with a biological therapy using stem cell differentiation. Instead of physically altering the gastrointestinal tract through surgical procedures, the therapy uses brown adipose-derived stem cells that differentiate into functional brown adipose tissue, achieving weight loss through metabolic mechanisms rather than mechanical structural changes, thereby eliminating surgical risks and complex postoperative management.
Solution Approach 2:
The patent introduces brown adipose-derived stem cells as an intermediary therapeutic agent between the patient and the desired weight loss outcome. These stem cells serve as a deliverable that, when introduced and differentiated, produce brown adipose tissue capable of increasing energy expenditure. This intermediary approach avoids the need for direct surgical intervention while still achieving the therapeutic goal of weight loss and morbidity reduction.
3Quantity of substance
If brown adipose-derived stem cells are cultured in two-dimensional (2D) format, then cell expansion is achieved, but three-dimensional tissue structure and natural architecture are lost
Solution Approach 1:
The patent applies dimensionality change by transitioning brown adipose-derived stem cells from two-dimensional monolayer culture to three-dimensional aggregate formation. The cells are cultured in suspended 3D aggregates that maintain their stem cell characteristics and differentiation potential while enabling natural three-dimensional tissue architecture. This 3D culture system allows cells to organize into structures that resemble in vivo tissue morphology, preserving both cell expansion capacity and structural integrity for subsequent implantation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of BAGs differentiated into brown adipose tissue within encapsulation systems has shown potential in increasing energy expenditure and treating metabolic disorders, endocrine disorders, cardiovascular disorders, and liver diseases by enhancing glucose tolerance and reducing body weight.
Implementation Method 1
brown adipose-derived stem cells that express one or more brown adipocyte gene in the absence of differentiation medium
Implementation Method 2
centrifuging the non-adherent culture plate to uniformly position the brown adipose-derived stem cells in the non-adherent culture plate, thereby forming three-dimensional brown adipose derived stem cell aggregates
Data Source
AI summary
The present application provides non-naturally occurring 3D brown adipose-derived stem cell (BADSC) aggregates, methods of making the 3D BADSC aggregates, and methods of using the 3D BADSC aggregates.